Sangamo Therapeutics Inc. (SGMO)

8.46
NASDAQ : Health Technology
Prev Close 8.46
Day Low/High 0.00 / 0.00
52 Wk Low/High 6.26 / 27.50
Avg Volume 1.86M
Exchange NASDAQ
Shares Outstanding 102.09M
Market Cap 890.25M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
The Return of Stock Market Volatility Can Create Stellar Opportunities

The Return of Stock Market Volatility Can Create Stellar Opportunities

But you need to be selective and have discipline.

SGMO Crosses Above Average Analyst Target

SGMO Crosses Above Average Analyst Target

In recent trading, shares of Sangamo Therapeutics Inc have crossed above the average analyst 12-month target price of $15.50, changing hands for $16.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Gains Elude Market as Momentum Withers

Gains Elude Market as Momentum Withers

Financial sector among the few bright spots.

How to Play This Cooling Momentum

How to Play This Cooling Momentum

We have shifted from a market that was mainly index driven by the FAANG names to one where stock picking is more important.

Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

Jim Cramer is bullish on Delta Air Lines, BioTelemetry, TransUnion, Amgen and Littelfuse.

Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap (Tues 10/17/17)

Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap (Tues 10/17/17)

Jim Cramer says there's a case to be made for underpricing, even in this market.

Paratek Shares Higher on Microbiology Data -- Biotech Movers

Paratek Shares Higher on Microbiology Data -- Biotech Movers

The Boston firm said microbiology data show that investigational antibiotic omadacycline is 'active against the clinically important typical and atypical community-acquired bacterial pneumonia (CABP) pathogens.'

Entry Points Are Tough, and Post-Labor Day Action Is Historically Poor

Entry Points Are Tough, and Post-Labor Day Action Is Historically Poor

I've cut a few positions and haven't made any notable buys today.

Sangamo Therapeutics Reaches Analyst Target Price

Sangamo Therapeutics Reaches Analyst Target Price

In recent trading, shares of Sangamo Therapeutics Inc have crossed above the average analyst 12-month target price of $12.60, changing hands for $12.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Interesting SGMO Put And Call Options For February 2018

Interesting SGMO Put And Call Options For February 2018

Investors in Sangamo Therapeutics Inc saw new options begin trading this week, for the February 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 197 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

September 15th Options Now Available For Sangamo Therapeutics (SGMO)

September 15th Options Now Available For Sangamo Therapeutics (SGMO)

Investors in Sangamo Therapeutics Inc saw new options become available today, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGMO options chain for the new September 15th contracts and identified one put and one call contract of particular interest.

Steady Climb Amid Low Volume

Bulls should curb their enthusiasm.

Short Interest Drops 16% For SGMO

Short Interest Drops 16% For SGMO

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 1,569,691 share decrease in total short interest for Sangamo Therapeutics Inc , to 8,230,673, a decrease of 16.02% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

We're Swimming in a Sea of Green This A.M.

We're Swimming in a Sea of Green This A.M.

There are few standout stocks, but there is broad strength so far today.

Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers

Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers

Seattle Genetics, FibroGen and Sangamo were among the biotech stock movers in premarket trading on June 26.

Shark Bites: Move Along, No Volatility to See Here

Shark Bites: Move Along, No Volatility to See Here

Only minor movement in the market.

Biotech Movers: Sangamo, Epizyme, Revance

Biotech Movers: Sangamo, Epizyme, Revance

Sangamo Therapeutics, Epizyme and Revance were among the biotech stock movers in premarket trading on June 21.

Sangamo Therapeutics Stock Sees Short Interest Make 16.5% Move

The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 1,311,426 share increase in total short interest for Sangamo Therapeutics Inc , to 9,274,371, an increase of 16.47% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Market Brushes Off Comey for More Interesting News

Market Brushes Off Comey for More Interesting News

Alibaba and Nordstrom are helping the bulls.

Shark Bites: Focus on the 'Little Picture'

Shark Bites: Focus on the 'Little Picture'

Here's what I'm trading today amid the 'flat with a positive tone' action.

Biotech Movers: Aratana Offering Priced Below Market, Shares Fall

Biotech Movers: Aratana Offering Priced Below Market, Shares Fall

Aratana Therapeutics, Trevena and Sangamo Therapeutics were among the biotech stock movers in premarket trading on Thursday.

Biotech Premarket Movers: Vertex, Sangamo, Depomed

Biotech Premarket Movers: Vertex, Sangamo, Depomed

Vertex Pharmaceuticals, Sangamo Therapeutics and Depomed were among the biotech stock movers in premarket trading on Wednesday.

Commit To Purchase Sangamo Therapeutics At $3, Earn 20.4% Annualized Using Options

Investors eyeing a purchase of Sangamo Therapeutics Inc stock, but tentative about paying the going market price of $4.18/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $3 strike, which has a bid at the time of this writing of 50 cents.

Biotech Premarket Movers: BioCryst, Sangamo, Cempra

Biotech Premarket Movers: BioCryst, Sangamo, Cempra

BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.

Biotech Premarket Movers: SGMO, IPXL, PTLA

Biotech Premarket Movers: SGMO, IPXL, PTLA

Sangamo Therapeutics, Impax Laboratories and Portola Pharmaceutical are among the premarket movers in biotech.

Biotech Premarket Movers: IPXL, SGMO, ARLZ

Biotech Premarket Movers: IPXL, SGMO, ARLZ

Impax Laboratories, Sangamo Therapeutics and Aralez Pharmaceuticals are among the premarket movers in biotech.

Short Interest Expands By 11.8% For SGMO

Short Interest Expands By 11.8% For SGMO

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 918,730 share increase in total short interest for Sangamo BioSciences Inc , to 8,679,778, an increase of 11.84% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday

Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday

Shares of Omeros fell almost 10% after analysts' downgraded the biotech.

Short Interest Falls 12.2% For SGMO

Short Interest Falls 12.2% For SGMO

The most recent short interest data has been released for the 09/15/2016 settlement date, which shows a 1,057,847 share decrease in total short interest for Sangamo BioSciences Inc , to 7,636,100, a decrease of 12.17% since 08/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of SGMO February 2017 Options Trading

First Week of SGMO February 2017 Options Trading

Investors in Sangamo BioSciences Inc saw new options begin trading this week, for the February 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D+ (Sell)